PBIRx, Inc., a national leader in pharmacy benefit consulting and auditing, is proud to announce exciting updates reflecting the growth and strength of its Clinical Operations team.
Andrew Reis, RPh, MBA has been named Director of Clinical Consultants. With over 20 years of experience in pharmacy benefit management, Andrew brings deep industry knowledge and leadership expertise from prior roles at OptumRx, Catamaran, and NMHCRx. At PBIRx, he leads strategic clinical initiatives and enhanced client-tailored pharmacy benefit solutions.
Victoria Khavulya, PharmD, Senior Clinical Pharmacy Consultant, has earned a certificate in Gene Therapy from Harvard Medical School’s HMX Pro program. With a background in specialty pharmacy and complex therapies, Victoria’s expertise continues to elevate PBIRx’s clinical guidance, especially in areas like fertility care, oncology, and gene therapy.
Nabil Khan, PharmD recently completed a Pharmacogenomics Certificate, reinforcing PBIRx’s dedication to precision medicine and cutting-edge clinical strategies. Nabil’s enhanced skillset supports personalized medication management, improving outcomes and reducing costs for clients and members.
“These accomplishments reflect our continued investment in clinical excellence,” said Patricia Sirowich, President and Director of Clinical Operations. “We are proud of our exceptional clinical team’s diverse expertise and dedication to delivering high-impact, cost-effective pharmacy benefit solutions.”
PBIRx is committed to procuring top-tier talent and enhancing clinical offerings as evidenced by these exciting developments. The firm continues to strive to empower its team members through advanced education and certifications, enabling PBIRx to deliver unparalleled pharmacy benefit consulting services tailored to the unique needs of its clients.
